The Safety and Efficacy of Basiliximab as Maintenance Therapy in Subjects With Stable, Noninfectious Uveitis
Status:
Terminated
Trial end date:
2008-11-01
Target enrollment:
Participant gender:
Summary
The objective of this trial is to assess if treatment with basiliximab allows subjects to
taper off other immunosuppressive drug regimens without causing an increase in their uveitis.